Gabriella Parma
Papers
1
Total Citations
181
H-Index
1
About
Gabriella Parma is a leading oncologist whose work has fundamentally shaped the clinical management of epithelial ovarian carcinoma, one of the most challenging gynecologic malignancies. Her research centers on optimizing treatment strategies for both newly diagnosed and relapsed disease, with a particular focus on translating evidence into actionable clinical guidelines. Parma’s most influential contribution is her authorship of the ESMO Clinical Practice Guidelines for ovarian cancer, a seminal work that has garnered over 180 citations and serves as a global reference for clinicians. This comprehensive framework integrates advances in surgical staging, platinum-based chemotherapy, and targeted therapies, directly improving patient outcomes through standardized, evidence-based care. Beyond guideline development, her research has explored novel therapeutic approaches and prognostic factors, bridging the gap between clinical trials and everyday practice. Parma’s work is distinguished by its practical impact—her guidelines are routinely cited in treatment decisions worldwide, reflecting her role as a key architect of modern ovarian cancer management. For students and researchers, her career exemplifies how rigorous clinical investigation can directly transform patient care, making her a vital figure in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1